Date: 2016-01-15
Type of information: Nomination
Compound:
Company: UCB (Belgium)
Therapeutic area: Bone diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On January 15, 2016, UCB announced that Pascale Richetta is joining the company as Executive Vice President, member of the Executive Committee and reporting to CEO Jean-Christophe Tellier. Pascale Richetta will head the Bone Patient Value Unit of UCB. The position was created last year as part of the company’s new Patient Value Organization. It had been filled ad interim by Iris Loew Friedrich who had taken on that extra role in addition to her responsibilities as Chief Medical Officer and Head of the Development and Medical Practices.
Pascale Richetta, a Medical Doctor, joins UCB from Abbvie where she was Vice President,Western Europe and Canada. Prior to this she held several management positions at Abbott, GSK, Ipsen and Servier, successfully launching these companies’ key drugs on several international markets.
Financial terms:
Latest news:
